Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.00 (0.00%)
Bid:
102.00
Ask:
106.00
Spread: 4.00 (3.922%)
Market Cap: £61.92m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Monthly Net Asset Value

11 Jan 2017 11:15

Crystal Amber Fund Limited - Monthly Net Asset Value

Crystal Amber Fund Limited - Monthly Net Asset Value

PR Newswire

London, January 11

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 11 January 2017 

CRYSTAL AMBER FUND LIMITED("Crystal Amber Fund” or the "Fund")

Monthly Net Asset Value

Crystal Amber Fund announces that its unaudited net asset value (“NAV”) per share at 31 December 2016 was 218.02p (30 November 2016: 196.64p per share). 

The proportion of the Fund’s NAV at 31 December 2016 represented by the ten largest holdings, other investments and cash (including accruals), was as follows:

Top ten holdingsPence per sharePercentage of investee equity held
Hurricane Energy Plc85.914.1%
Grainger Plc34.33.4%
Northgate Plc31.74.7%
STV Group Plc19.913.9%
Leaf Clean Energy Co.12.629.9%
FairFX Group8.825.5%
Sutton Harbour Holdings Plc7.529.3%
Hansard Global Plc4.73.3%
Camellia Plc2.60.9%
Shepherd Neame Ltd2.51.3%
Total of ten largest holdings210.5
Other investments14.6
Cash and accruals(7.1)
Total NAV218.0

Investment Adviser’s commentary on the portfolio

Over the quarter to 31 December 2016, NAV per share increased by 7.9 per cent. This return is calculated after providing for a 2.5p per share dividend declared on 14 December 2016 in respect of the year ending 30 June 2017. Adjusting for this dividend, total returns in the quarter were 9.2 per cent. For the six months to 31 December 2016, NAV per share increased by 41.8 per cent. Adjusting for dividends of 5p a share declared during the period, total returns were 45.0 per cent.

The top three positive contributors to NAV growth over the quarter to 31 December 2016 were Hurricane Energy plc (10.6%), Northgate plc (2.1%) and Grainger (0.8%). The main detractors were Leaf Clean Energy Co (-0.9%), STV Group plc (-0.8%) and Sutton Harbour Holdings plc (-0.4%). 

Hurricane Energy plc (“Hurricane”)

During the Quarter, Hurricane released several positive drilling results and raised £70 million to fund drilling an exploration well at Lincoln, to acquire subsea equipment and to fund engineering studies for the Early Production System phase of the Lancaster development.

Crystal Amber was pleased to participate in the fundraising, investing a further £10.7 million in line with the Fund’s stake in the company at the time of 15.3%.

In November 2016, Hurricane was awarded a new licence (Halifax) in its West of Shetland acreage, further expanding the footprint beyond its Lancaster oil asset. Further exploration of this prospect has the potential to not only increase Hurricane’s resource base, but also to help determine how far the Lancaster field extends.

On 19 December 2016, Hurricane announced very positive interim results at its Lincoln exploration well, adding to its increasingly substantial resource base. Results demonstrated a 660m deep oil column which exceeded the company’s expectations and led to the company stating that the pre-drill estimate of 250 million barrels may be conservative. Hurricane’s drill rig will now be moved on to drill the Halifax prospect. 

Recent drilling results reinforce the Fund’s view that Hurricane has a significant resource base, potentially in excess of one billion barrels of oil. We expect to see further positive news flow over the coming months, which should serve to de-risk the asset base further and may attract potential partners.

Over the quarter, Hurricane’s share price increased by 26.8 per cent.

Northgate plc (“Northgate”)

On 6 December 2016, Northgate announced interim results broadly in line with expectations. The company stated that the UK business has stabilised and vehicle hires were increasing. The Spanish division continues to develop well. 

In December 2016, Northgate announced the departure of its CEO, Bob Contreras, and the appointment of a new CEO, Kevin Bradshaw, former CEO of Wyevale Garden Centres and former UK CEO of Avis Europe. The Fund welcomes this development: in July 2016, the Fund announced that it had called on Northgate to carry out a strategic review to include a potential sale of the business.

The Fund maintains the view that there is a significant opportunity to better capitalise on the Northgate brand and market positioning. The Fund also notes that Northgate’s shares trade on a historic PE ratio of 10.5 and regards the company as attractive to acquisitive investors in the sector.

Over the quarter, Northgate’s share price increased by 12.5 per cent. 

Grainger plc (“Grainger”)

On 1 December 2016, Grainger announced positive full year results, highlighting progress in refocusing and improving the efficiency of the business. 

The Fund continues to engage with Grainger’s management regarding optimising capital structures and balance sheet efficiency. Despite improved focus and a reduction in the previous excessive administrative cost base, Grainger’s shares continue to trade at a significant discount to its net asset value of 287p a share. This figure excludes 78p a share of reversionary surpluses accruing to Grainger as its reversionary portfolio becomes vacant.

Over the quarter, Grainger’s share price increased by 3.3 per cent. 

STV Group plc (“STV”)

In December 2016, STV announced that an agreement had been reached with the trustees of the company’s defined benefits schemes. The Fund welcomes this development and believes that it will allow STV to provide greater clarity on how it will deploy capital. This could involve increasing the dividend payout or a share buyback. 

Although television advertising revenues have come under some pressure as a result of Brexit uncertainty (as evidenced by ITV’s trading update in December 2016), the Fund maintains the view that STV holds a strong franchise with a fast-growing consumer division and valuable production content activities. Trading on 10 times current year consensus earnings, the Fund regards STV as undervalued and an attractive takeover target.

Over the quarter, STV’s share price fell by 4.7 per cent.

For further enquiries please contact:

Crystal Amber Fund LimitedWilliam Collins (Chairman)Tel: 01481 716 000www.crystalamber.comAllenby Capital Limited - Nominated AdviserDavid Worlidge/James ThomasTel: 020 3328 5656Winterflood Investment Trusts - BrokerJoe Winkley/Neil LangfordTel: 020 3100 0160Crystal Amber Advisers (UK) LLP – Investment AdviserRichard BernsteinTel: 020 7478 9080

Date   Source Headline
22nd May 20261:07 pmRNSMonthly Net Asset Value
6th May 202612:54 pmRNSPurchase of Ordinary Shares by Tarncourt
30th Apr 20265:00 pmRNSTotal Voting Rights
22nd Apr 20262:54 pmRNSMonthly Net Asset Value
22nd Apr 20269:47 amRNSResult of EGM
16th Apr 20265:19 pmRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20265:03 pmRNSTransaction in Own Shares and Total Voting Rights
8th Apr 202610:51 amRNSTransaction in Own Shares and Total Voting Rights
1st Apr 20265:41 pmRNSDirector/PDMR Shareholding
31st Mar 20265:00 pmRNSTotal Voting Rights
31st Mar 20267:01 amRNSHalf-year Report
31st Mar 20267:00 amRNSPosting of Circular and Notice of EGM
26th Mar 20264:25 pmRNSMonthly Net Asset Value
16th Mar 20264:29 pmRNSNotice of results; update re strategy and manager
2nd Mar 202611:49 amRNSMonthly Net Asset Value
2nd Mar 202611:30 amRNSTotal Voting Rights
25th Feb 20266:17 pmRNSTransaction in Own Shares and Total Voting Rights
24th Feb 20265:26 pmRNSTransaction in Own Shares and Total Voting Rights
20th Feb 20265:44 pmRNSTransaction in Own Shares and Total Voting Rights
18th Feb 20265:04 pmRNSTransaction in Own Shares and Total Voting Rights
16th Feb 20264:04 pmRNSUpdate on Morphic Medical Inc.
13th Feb 20265:21 pmRNSTransaction in Own Shares and Total Voting Rights
12th Feb 20264:58 pmRNSTransaction in Own Shares and Total Voting Rights
11th Feb 20265:02 pmRNSTransaction in Own Shares and Total Voting Rights
10th Feb 20265:29 pmRNSTransaction in Own Shares and Total Voting Rights
9th Feb 20265:40 pmRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20266:24 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Feb 20265:59 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Feb 20266:20 pmRNSTransaction in Own Shares and Total Voting Rights
30th Jan 20265:30 pmRNSTotal Voting Rights
29th Jan 20265:18 pmRNSTransaction in Own Shares and Total Voting Rights
29th Jan 202610:38 amRNSMonthly Net Asset Value
27th Jan 20269:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20265:21 pmRNSTransaction in Own Shares and Total Voting Rights
19th Jan 20266:17 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jan 202612:32 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jan 202612:18 pmRNSReplacement: Update and corrections regarding TVRs
16th Jan 20267:00 amRNSReplacement: Transaction in Own Shares and TVR
16th Jan 20267:00 amRNSUpdate & corrections regarding total voting rights
12th Jan 20265:46 pmRNSCancellation of treasury shares
6th Jan 20265:18 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jan 20265:31 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Dec 20251:30 pmRNSTotal Voting Rights
31st Dec 20251:30 pmRNSTotal Voting Rights
29th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Dec 20255:30 pmRNSTransaction in Own Shares and Total Voting Rights
22nd Dec 20254:48 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.